cbdMD (NYSEAMERICAN:YCBD) Trading Down 2.5% – Should You Sell?

Shares of cbdMD, Inc. (NYSEAMERICAN:YCBDGet Free Report) traded down 2.5% during mid-day trading on Thursday . The company traded as low as $0.43 and last traded at $0.43. 14,371 shares changed hands during trading, a decline of 91% from the average session volume of 154,805 shares. The stock had previously closed at $0.44.

cbdMD Trading Up 18.6 %

The firm has a market cap of $1.92 million, a PE ratio of -0.05 and a beta of 2.01. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.52 and a current ratio of 0.93.

cbdMD (NYSEAMERICAN:YCBDGet Free Report) last posted its quarterly earnings data on Wednesday, August 14th. The company reported ($0.15) EPS for the quarter. cbdMD had a negative return on equity of 350.55% and a negative net margin of 96.00%. The firm had revenue of $5.17 million for the quarter.

cbdMD Company Profile

(Get Free Report)

cbdMD, Inc produces and distributes various cannabidiol (CBD) products. The company owns and operates consumer hemp-based CBD brands, such as cbdMD, Paw CBD, hempMD, and cbdMD Botanicals. Its cbdMD brand products include CDB tinctures, gummies, topicals, capsules, drink mixes, and sleep, focus, and calming aids.

Read More

Receive News & Ratings for cbdMD Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for cbdMD and related companies with MarketBeat.com's FREE daily email newsletter.